👤 Kai Guo

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧬 Extraction
804
Articles
572
Name variants
Also published as: Aiyuan Guo, Alex Guo, An-Yuan Guo, AoHan Guo, Ava Jiangyang Guo, Baihai Guo, Baosheng Guo, Baozhu Guo, Bei Guo, Beibei Guo, Bianqin Guo, Bin Guo, Binbin Guo, Bing-Yan Guo, Bingnan Guo, Bingpeng Guo, Bo Guo, Caixia Guo, Chang Guo, Changfa Guo, Changjiang Guo, Changkui Guo, Changyuan Guo, Chao Guo, Chen Guo, Cheng Guo, Chengcheng Guo, Chenghang Guo, Chenglin Guo, Chengnan Guo, Chengxian Guo, Chengyao Guo, Chenkai Guo, Chenxu Guo, Christina Guo, Chu Guo, Chuang Guo, Chuanyu Guo, Chuanzhi Guo, Chun Guo, Chun-Hua Guo, Chunhe Guo, Chunjie Guo, Chunyuan Guo, Cong Guo, Cui Guo, Cuiping Guo, Cunlan Guo, Dachuan Guo, Dan Guo, Daoxia Guo, Daqiao Guo, Dazhi Guo, Deng F Guo, Deng Fu Guo, Deng-Fu Guo, Detong Guo, Diana E Guo, Dong Guo, Dong-Yu Guo, Dong-ping Guo, DongMing Guo, Dongchuan Guo, Donghao Guo, Donghui Guo, Dongjie Guo, Dongping Guo, Fang Guo, Fang-Fang Guo, Fang-hong Guo, Fangfang Guo, Fangliang Guo, Fangling Guo, Fanli Guo, Feng Guo, Fenghua Guo, Fengjin Guo, Fengqin Guo, Fengyun Guo, Fujia Guo, Gao Guo, Ge Guo, Gengyin Guo, Grace L Guo, Guanghao Guo, Guangqiong Guo, Guangran Guo, Guangwu Guo, Guijie Guo, Guilong Guo, Guiya Guo, Guiyuan Guo, Guoji Guo, H D Guo, Hai-Hui Guo, Hai-Lei Guo, Hai-Long Guo, Haidan Guo, Haihong Guo, Hailong Guo, Haiyan Guo, Hang Guo, Hanrui Guo, Hao Guo, Haoliang Guo, Haonan Guo, Haoran Guo, Haoyao Guo, Hejiang Guo, Heng Guo, Hengru Guo, Hong Guo, Hong-Li Guo, Hongbo Guo, Honghui Guo, Hongjuan Guo, Honglin Guo, Hongqian Guo, Hongquan Guo, Hongrui Guo, Hongyan Guo, Hongyu Guo, Hu Guo, Hua Guo, Hua-Qi Guo, Huan Guo, Huaqi Guo, Huaxin Guo, Hui Guo, Huicai Guo, Huichen Guo, Huiduo Guo, Huifang Guo, Huilan Guo, J Guo, Ji-Feng Guo, Jia Guo, Jia-Ni Guo, Jiabao Guo, Jiahao Guo, Jiahe Guo, Jiahong Guo, Jiajun Guo, Jiali Guo, Jialu Guo, Jian Guo, Jianbin Guo, Jianfeng Guo, Jianhong Guo, Jianhui Guo, Jianlin Guo, Jianming Guo, Jianping Guo, Jianqiang Guo, Jianrong Guo, Jianwen Guo, Jianxing Guo, Jiao Guo, Jiaona Guo, Jiaqi Guo, Jiarui Guo, Jiasong Guo, Jiayu Guo, Jiazhong Guo, Jiazhuo Guo, Jichang Guo, Jie Guo, Jifeng Guo, Jin Guo, Jinbai Guo, Jing Guo, Jing-Feng Guo, Jingbin Guo, Jingjing Guo, Jingxu Guo, Jingxuan Guo, Jingyi Guo, Jinhao Guo, Jinjun Guo, Jinlei Guo, Jinming Guo, Jinshuo Guo, Jinxuan Guo, Jinyan Guo, Jinzhen Guo, Jiurui Guo, Jiwei Guo, Jizhen Guo, Joan Guo, Joanna Guo, Jonathan Guo, Ju Guo, Juan Guo, Jun Guo, Jun-Jie Guo, Jun-Rong Guo, Junfei Guo, Junhong Guo, Junjie Guo, Junming Guo, Junpeng Guo, Junqiao Guo, Junweichen Guo, Junyi Guo, Kaifeng Guo, Kailei Guo, Kailu Guo, Kaixuan Guo, Kaiyu Guo, Kangkang Guo, Katherine Guo, Keji Guo, Kevin Guo, Kexin Guo, Keying Guo, Kun Guo, Kun-yuan Guo, L Guo, Lan Guo, Lan-Fang Guo, Landys Z Guo, Lanfang Guo, Lanping Guo, Lei Guo, Li Guo, Li-Jie Guo, Li-Ying Guo, Li-Zhe Guo, Liang Guo, Liang-Hong Guo, Lianrui Guo, Lianxia Guo, Lichen Guo, Lihe Guo, Lijuan Guo, Lijun Guo, Lin Guo, Linfeng Guo, Ling Guo, Ling-Li Guo, Lingyi Guo, Lining Guo, Liping Guo, Lishuang Guo, Liuliu Guo, Liuxiong Guo, Lixin Guo, Liyi Guo, Lizhong Guo, Longchao Guo, Longhua Guo, Longyu Guo, Lu Guo, Man Guo, Manman Guo, Mei Guo, Meng Guo, Meng-Yao Guo, Mengdi Guo, Menghan Guo, Mengmeng Guo, Mengqin Guo, Mengran Guo, Mengru Guo, Mengyu Guo, Miaomiao Guo, Min Guo, Minfang Guo, Ming Guo, Mingwei Guo, Mingxuan Guo, Mingzhou Guo, Minkang Guo, Mixue Guo, N Guo, Na Guo, Nan Guo, Nana Guo, Ni Guo, Ning Guo, Ninghong Guo, Ningning Guo, Peilan Guo, Peipei Guo, Peiran Guo, Peng Guo, Pengchao Guo, Pengrong Guo, Pengwang Guo, Pengyu Guo, Ping Guo, Qi Guo, Qi Wei Guo, Qian Guo, Qiang Guo, Qianjin Guo, Qianqian Guo, Qianxue Guo, Qianyu Guo, Qin Guo, Qing Guo, Qingjun Guo, Qiufen Guo, Qiusha Guo, Qiuxiao Guo, Qiuyu Guo, Qunfeng Guo, R Guo, R J Guo, Ren Guo, Rong Guo, Rongjun Guo, Rui Guo, Ruijuan Guo, Ruixian Guo, Ruixue Guo, Runlin Guo, Ruoling Guo, Ruoyi Guo, S Guo, Sen Guo, Shanchun Guo, Sheng Guo, Shiping Guo, Shiqi Guo, Shixiang Guo, Shiyu Guo, Shou-Dong Guo, Shou-Gang Guo, Shoudong Guo, Shougang Guo, Shu-Li Guo, Shu-Liang Guo, Shuai Guo, Shuaijun Guo, Shuang Guo, Shubin Guo, Shufei Guo, Shujie Guo, Shun Guo, Shunyuan Guo, Shupan Guo, Shuren Guo, Shushu Guo, Shuxia Guo, Siqing Guo, Sixian Guo, Siyu Guo, Song-Chang Guo, Sufen Guo, Suping Guo, Suxiang Guo, Tao Guo, Tengfei Guo, Theresa Guo, Tianyi Guo, Tianyu Guo, Ting Guo, Tingting Guo, Tingwei Guo, Tingxi Guo, Tong Guo, W X Guo, Wanjun Guo, Wanrong Guo, Wei Guo, Wei-Xing Guo, Weichun Guo, Weidong Guo, Weihong Guo, Weihua Guo, Weijie Guo, Weiqiang Guo, Weisheng Guo, Weiwei Guo, Weiying Guo, Wen Guo, Wen-Wen Guo, Wenhuang Guo, Wenhui Guo, Wenjie Guo, Wenjing Guo, Wenjuan Guo, Wenting Guo, Wenwen Guo, Wenxing Guo, Wenxuan Guo, Wubin Guo, X Guo, Xi-Rong Guo, Xi-Xi Guo, Xia Guo, Xiajun Guo, Xian Guo, Xianfei Guo, Xiang Guo, Xianghao Guo, Xiangjiang Guo, Xiangqian Guo, Xianzhi Guo, Xiao Guo, Xiao Quan Guo, Xiao-Nan Guo, Xiao-Xi Guo, Xiao-Yu Guo, Xiao-yan Guo, XiaoYan Guo, Xiaobin Guo, Xiaochen Guo, Xiaodi Guo, Xiaofan Guo, Xiaofei Guo, Xiaoge Guo, Xiaohong Guo, Xiaohua Guo, Xiaohui Guo, Xiaojun Guo, Xiaolan Guo, Xiaoliang Guo, Xiaolin Guo, Xiaoling Guo, Xiaonan Guo, Xiaoping Guo, Xiaoqiang Guo, Xiaoquan Guo, Xiaoxian Guo, Xiaoye Guo, Xiaoying Guo, Xiaoyu Guo, Xiaozhong Guo, Xieli Guo, Xin Guo, Xing Guo, Xingjun Guo, Xingmei Guo, Xingyi Guo, Xingyou Guo, Xinli Guo, Xinru Guo, Xinyi Guo, Xinyin Guo, Xiong Guo, Xirong Guo, Xiuqing Guo, Xiying Guo, Xizhi Guo, Xu Guo, Xudong Guo, Xue-Ling Guo, Xuejiang Guo, Xuewu Guo, Xuyang Guo, Y H Guo, Y J Guo, Y S Guo, Y-M Guo, Ya-Dong Guo, Ya-Gang Guo, Yajie Guo, Yamin Guo, Yan Guo, Yan-Xia Guo, Yane Guo, Yang Guo, Yangbo Guo, Yangdong Guo, Yangfan Guo, Yanhong Guo, Yanhua Guo, Yanjie Guo, Yanjun Guo, Yanlei Guo, Yanli Guo, Yannan Guo, Yanwei Guo, Yanzhi Guo, Yaping Guo, Yarong Guo, Yaru Guo, Yatu Guo, Yaxin Guo, Yazhou Guo, Yelei Guo, Yi Guo, Yi-Cheng Guo, Yi-Jing Guo, Yi-Ran Guo, Yifan Guo, Yifang Guo, Yifei Guo, Yilei Guo, Yimo Guo, Ying Guo, Ying'ao Guo, Ying-Yuan Guo, Yingying Guo, Yishan Guo, Yong Guo, Yong-Chen Guo, Yongjun Guo, Yongmei Guo, Yongqing Guo, Yongzhen Guo, Yongzheng Guo, Youming Guo, Yu Guo, Yu-Jie Guo, Yu-Li Guo, Yuan Guo, Yuan-Lin Guo, Yuanbiao Guo, Yuanfang Guo, Yuanlin Guo, Yue Guo, Yuetong Guo, Yujia Guo, Yujie Guo, Yulong Guo, Yumeng Guo, Yuming Guo, Yunliang Guo, Yunxia Guo, Yunxuan Guo, Yunxue Guo, Yunyun Guo, Yuqi Guo, Yuquan Guo, Yushan Guo, Yutong Guo, Yuwen Guo, Yuxian Guo, Zeao Guo, Zexi Guo, Zeyi Guo, Zhaohui Guo, Zhaojuan Guo, Zhen Guo, Zhen-Ya Guo, Zheng-Chen Guo, Zhengguang Guo, Zhengwang Guo, Zhengyan Guo, Zhengzhang Guo, Zhenli Guo, Zhenming Guo, Zhenye Guo, Zhenzhen Guo, Zhi-Gang Guo, Zhibo Guo, Zhijian Guo, Zhilei Guo, Zhimin Guo, Zhiru Guo, Zhiting Guo, Zhizhao Guo, Zhongbao Guo, Zhongqiang Guo, Zhongwei Guo, Zhongyuan Guo, Zhou Guo, Zhouli Guo, Zhu-Ling Guo, Ziang Guo, Zifang Guo, Zihan Guo, Ziming Guo, Zipei Guo, Zisheng Guo, Ziwei Guo, Ziwen Guo, Zufeng Guo
articles
Xiaosi Yu, Juan Guo, Qian Zhou +3 more · 2021 · Breast cancer (Tokyo, Japan) · Springer · added 2026-04-24
To find immune-related genes with prognostic value in breast cancer, and construct a prognostic risk assessment model to make a more accurate assessment. Moreover, looking for potential immune markers Show more
To find immune-related genes with prognostic value in breast cancer, and construct a prognostic risk assessment model to make a more accurate assessment. Moreover, looking for potential immune markers for breast cancer immunotherapy. The breast cancer (BC) data were retrieved from The Cancer Genome Atlas (TCGA) database as a training set. Through the Weighted gene co-expression network analysis (WGCNA), Kaplan-Meier (KM) analysis, lasso regression analysis and stepwise backward Cox regression analysis, screening for prognosis-related immune genes, a prognostic index was built, and external validation with two data sets of Gene Expression Omnibus (GEO) database was performed. Transcription factor (TF) regulatory network was constructed to identify key transcription factors that regulate prognostic immune genes. Gene set enrichment analysis (GSEA) was used to explore the signal pathways differences between high and low-risk groups, estimate package and TIMER database were used to evaluate the relationship between risk score and tumor immune microenvironment. We obtained 10 prognosis-related immune genes, and the index showed accurate prognostic value. We also identified 7 prognostic transcription factors. Multiple signaling pathways that inhibit tumor progression were enriched in the low-risk group, and risk score was significantly negatively related to the degree of immune infiltration and the expression level of immune checkpoint genes. We successfully constructed an independent prognostic index, which not only has a stronger predictive ability than the tumor pathological stage, but also can reflect the immune infiltration of breast cancer patients. Show less
no PDF DOI: 10.1007/s12282-020-01175-z
NR1H3
Wenhui Guo, Jingyi Li, Haobo Huang +3 more · 2021 · Frontiers in oncology · Frontiers · added 2026-04-24
Long non-coding RNAs (LncRNA) as the key regulators in all stages of tumorigenesis and metastasis. However, the underlying mechanisms are largely unknown. Here, we report a lncRNA RP11-214F16.8, which Show more
Long non-coding RNAs (LncRNA) as the key regulators in all stages of tumorigenesis and metastasis. However, the underlying mechanisms are largely unknown. Here, we report a lncRNA RP11-214F16.8, which renamed Lnc-PCIR, is upregulated and higher RNA level of Lnc-PCIR was positively correlated to the poor survival of patients with triple negative breast cancer (TNBC) tissues. Lnc-PCIR overexpression significantly promoted cell proliferation, migration, and invasion Show less
no PDF DOI: 10.3389/fonc.2021.630300
PABPC4
Chuanyin Li, Tianting Han, Qingrun Li +15 more · 2021 · Nucleic acids research · Oxford University Press · added 2026-04-24
The family of Poly(A)-binding proteins (PABPs) regulates the stability and translation of messenger RNAs (mRNAs). Here we reported that the three members of PABPs, including PABPC1, PABPC3 and PABPC4, Show more
The family of Poly(A)-binding proteins (PABPs) regulates the stability and translation of messenger RNAs (mRNAs). Here we reported that the three members of PABPs, including PABPC1, PABPC3 and PABPC4, were identified as novel substrates for MKRN3, whose deletion or loss-of-function mutations were genetically associated with human central precocious puberty (CPP). MKRN3-mediated ubiquitination was found to attenuate the binding of PABPs to the poly(A) tails of mRNA, which led to shortened poly(A) tail-length of GNRH1 mRNA and compromised the formation of translation initiation complex (TIC). Recently, we have shown that MKRN3 epigenetically regulates the transcription of GNRH1 through conjugating poly-Ub chains onto methyl-DNA bind protein 3 (MBD3). Therefore, MKRN3-mediated ubiquitin signalling could control both transcriptional and post-transcriptional switches of mammalian puberty initiation. While identifying MKRN3 as a novel tissue-specific translational regulator, our work also provided new mechanistic insights into the etiology of MKRN3 dysfunction-associated human CPP. Show less
no PDF DOI: 10.1093/nar/gkab155
PABPC4
Ruixia Zhu, Yating Zhao, Dandan Tian +3 more · 2021 · American journal of translational research · added 2026-04-24
In the past decade, an increasing number of genome-wide association studies (GWASs) have been applied to ischemic stroke (IS) susceptibility and recovery. In our study, six GWAS-linked hot loci (
no PDF
PATJ
Huiling Ren, Xin Yin, Chao Su +5 more · 2021 · Autophagy · Taylor & Francis · added 2026-04-24
The innate immune restriction factor SAMHD1 can inhibit diverse viruses in myeloid cells. Mechanistically, SAMHD1 inhibits lentiviral replication including HIV-1 by depleting the nucleotide pool to in Show more
The innate immune restriction factor SAMHD1 can inhibit diverse viruses in myeloid cells. Mechanistically, SAMHD1 inhibits lentiviral replication including HIV-1 by depleting the nucleotide pool to interfere with their reverse transcription. Equine infectious anemia virus (EIAV) is an ancient lentivirus that preferentially attacks macrophages. However, the mechanism by which EIAV successfully establishes infection in macrophages with functional SAMHD1 remains unclear. Here, we demonstrate that while equine SAMDH1 can limit EIAV replication in equine macrophages at the reverse transcription stage, the antiviral effect is counteracted by the well-known transcriptional regulator Rev, which downregulates equine SAMHD1 through the lysosomal pathway. Remarkably, Rev hijacks BECN1 (beclin 1) and PIK3C3 to mediate SAMHD1 degradation in a canonical macroautophagy/autophagy-independent pathway. Our study illustrates that equine lentiviral Rev possesses important functions in evading cellular innate immunity in addition to its RNA regulatory function, and may provide new insights into the co-evolutionary arms race between SAMHD1 and lentiviruses. Show less
no PDF DOI: 10.1080/15548627.2020.1846301
PIK3C3
Elizabeth Robins, Ming Zheng, Qingshan Ni +9 more · 2021 · Cellular & molecular immunology · Nature · added 2026-04-24
CD4
no PDF DOI: 10.1038/s41423-019-0347-5
PIK3C3

Decreased

Qianli Ma, Jin Zhang, Jingjing Huang +11 more · 2021 · Translational lung cancer research · added 2026-04-24
Early-stage female lung adenocarcinoma is the most common type of lung cancer encountered in thoracic surgery departments. Tumor-node-metastasis (TNM) staging does not adequately explain a significant Show more
Early-stage female lung adenocarcinoma is the most common type of lung cancer encountered in thoracic surgery departments. Tumor-node-metastasis (TNM) staging does not adequately explain a significant stratification phenomenon in the prognosis of patients with stage I lung adenocarcinoma. We aimed to investigate the contributory role of We analyzed the microRNA (miRNA) expression level in tumor tissues (high-risk group In all, 24 miRNAs were found to be significantly different between the high-risk group and low-risk group. The expression level of The present study showed that Show less
no PDF DOI: 10.21037/tlcr-21-906
SNAI1
Yanli Guo, Pingping Sun, Wei Guo +5 more · 2021 · Bioengineered · Taylor & Francis · added 2026-04-24
LncRNA DDX11 antisense RNA 1 (DDX11-AS1) is recognized as having an imperative oncogenic role in different types of human cancer. Nevertheless, the functions, as well as the basic mechanisms of DDX11- Show more
LncRNA DDX11 antisense RNA 1 (DDX11-AS1) is recognized as having an imperative oncogenic role in different types of human cancer. Nevertheless, the functions, as well as the basic mechanisms of DDX11-AS1 in the EMT process of esophageal squamous cell carcinoma (ESCC), are yet to be clarified. In this research, high DDX11-AS1 expression was detected in ESCC cells as well as tissues and was linked to the poor prognosis of patients with ESCC. DDX11-AS1 promoted cell proliferation, migration, invasion ability and epithelial mesenchymal transition (EMT) process in vitro. Mechanistic analysis depicted that DDX11-AS1 may function as a ceRNA through sponging miR-30d-5p to upregulate the expression of SNAI1 and ZEB2. Meanwhile, overexpression of DDX11-AS1 might cause the activation of the Wnt/β-catenin signaling pathway via targeting miR-30d-5p. On the whole, the findings of this research illustrate that DDX11-AS1 may act as an EMT-related lncRNA to advance ESCC progression through sponging miR-30d-5p to regulate SNAI1/ZEB2 expression and activate the Wnt/β-catenin pathway, which indicates that it might serve as a probable therapeutic target for ESCC. Show less
no PDF DOI: 10.1080/21655979.2021.2008759
SNAI1
Zhaoping Qiu, Bo Dong, Weijie Guo +7 more · 2021 · Theranostics · added 2026-04-24
SNAI1 is widely regarded as a master driver of epithelial-mesenchymal transition (EMT) and associated with breast cancer progression and metastasis. This pro-malignant role is strongly linked to postt Show more
SNAI1 is widely regarded as a master driver of epithelial-mesenchymal transition (EMT) and associated with breast cancer progression and metastasis. This pro-malignant role is strongly linked to posttranslational modification, especially phosphorylation, which controls its protein levels and subcellular localization. While multiple kinases are implicated in regulation of SNAI1 stability, the precise mechanism by which SNAI1 is stabilized in tumors remains to be fully elucidated. Show less
no PDF DOI: 10.7150/thno.62406
SNAI1
Wenqing Huang, Jianxiong Chen, Xunhua Liu +8 more · 2021 · Experimental cell research · Elsevier · added 2026-04-24
Breast cancer is one of the most frequently diagnosed cancers and the leading cause of cancer death in women. MIER3 (Mesoderm induction early response 1, family member3) is considered as a potential o Show more
Breast cancer is one of the most frequently diagnosed cancers and the leading cause of cancer death in women. MIER3 (Mesoderm induction early response 1, family member3) is considered as a potential oncogene for breast cancer. However, the role of MIER3 in breast cancer remain largely unknown. The expression of MIER3 was detected and the relationship between its expression and clinicopathological characteristics was also analyzed. The effect of MIER3 on proliferation and migration of breast cancer cells was detected in vitro and in vivo. Western blot, IF, and Co-IP were employed to detect the relationship between MIER3, HDAC1, HDAC2, and Snail. ChIP assay was performed to determine the binding of MIER3/HDAC1/HDAC2/Snail complex to the promoter of E-cadherin. In this study, we found that MIER3 was upregulated in breast cancer tissue and closely associated with poor prognosis of patients. MIER3 could promote the proliferation, migration, and epithelial-mesenchymal transition (EMT) of breast cancer cells. Further studies showed that MIER3 interacted with HDAC1/HDAC2 and Snail to form a repressive complex which could bind to E-cadherin promoter and was related to its deacetylation. Our study concluded that MIER3 was involved in forming a co-repressor complex with HDAC1/HDAC2/Snail to promote EMT by silencing E-cadherin. Show less
no PDF DOI: 10.1016/j.yexcr.2021.112722
SNAI1
Wenwei Hao, Yongping Zhu, Ying Guo +1 more · 2021 · Transplant immunology · Elsevier · added 2026-04-24
Chronic rhinosinusitis is an intractable symptom that influences daily lives of patients. miR-1287-5p was discovered to play a suppressive role in cervical cancer and HBV-related infection. This study Show more
Chronic rhinosinusitis is an intractable symptom that influences daily lives of patients. miR-1287-5p was discovered to play a suppressive role in cervical cancer and HBV-related infection. This study investigated the potential role of miR-1287-5p in the in-vitro model of chronic rhinosinusitis. GSE169376 dataset was analyzed and differential miRNAs in nasal mucosa tissues in the chronic rhinosinusitis group were screened out. LPS was used to treat HNECs for 12h, 24h and 48h. Cells underwent LPS treatment after SNAI1 downregulation, miR-1287-5p upregulation or pretreatment of the HMGB1 inhibitor, Glycyrrhizin. RT-PCR was used to measure the RNA expression of miR-1287-5p, SNAI1 and HMGB1. ELISA was used for the detection of IL-6, IL-8, TNF-α changes. Targetscan and starBase were used to predict the targets (SNAI1 and HMGB1) of miR-1287-5p. Dual-luciferase reporter assays were applied to validate this. Western blot was used to analyze the protein changes of Snai1, Vimentin, E-cadherin and HMGB1. miR-1287-5p was downregulated in the chronic rhinosinusitis group and decreased after LPS treatment in HNECs. The upregulation of miR-1287-5p inhibited IL-6, IL-8, TNF-α and EMT. miR-1287-5p targeted and inhibited SNAI1 and HMGB1. SNAI1 downregulation led to inhibition in EMT while loss of HMGB1 contributed to the decrease in pro-inflammatory cytokines. Knockdown of SNAI1 decreased HMGB1, resulting in the reduction of pro-inflammatory cytokines while HMGB1 inhibitor reduced SNAI1 and thus suppressed the EMT process. miR-1287-5p downregulation was associated with chronic rhinosinusitis and its upregulation inhibited the EMT and inflammation in LPS-induced HNECs through Snai1/HMGB1 pathway. Show less
no PDF DOI: 10.1016/j.trim.2021.101429
SNAI1
Minghua Li, Xia Long, Huijuan Wan +4 more · 2021 · Cell biology international · Wiley · added 2026-04-24
One hallmark of renal cell carcinoma (RCC) is metabolic reprogramming, which involves elevation of glycolysis and upregulation of lipid metabolism. However, the mechanism of metabolic reprogramming is Show more
One hallmark of renal cell carcinoma (RCC) is metabolic reprogramming, which involves elevation of glycolysis and upregulation of lipid metabolism. However, the mechanism of metabolic reprogramming is incompletely understood. Monocarboxylate transporter 1 (MCT1) promotes transport for lactate and pyruvate, which are crucial for cell metabolism. The aim of present study was to investigate the function of MCT1 on RCC development and its mechanism on metabolic reprogramming. The results showed that MCT1 messenger RNA and protein levels significantly increased in cancer tissues of ccRCC compared to normal tissue. MCT1 was further found to mainly located in the cell membrane of RCC. The knockdown of MCT1 by RNAi significantly inhibited proliferation and migration of 786-O and ACHN cells. MCT1 also induced the expressions of proliferation marker Ki-67 and invasion marker SNAI1. Moreover, we also showed that acetate treatment could upregulate the expression of MCT1, but not other MCT isoforms. On the other hand, MCT1 was involved in acetate transport and intracellular histone acetylation. In summary, this study revealed that MCT1 is abnormally high in ccRCC and promotes cancer development. The regulatory effect of MCT1 on cell proliferation and invasion maybe mediated by acetate transport. Show less
no PDF DOI: 10.1002/cbin.11571
SNAI1
Junhui Yu, Shan Li, Zhengshui Xu +5 more · 2021 · British journal of cancer · Nature · added 2026-04-24
Emerging evidence suggests the involvement of caudal-related homoeobox transcription factor 2 (CDX2) in tumorigenesis of various cancers. Although CDX2 functions in cancer invasion and metastasis, few Show more
Emerging evidence suggests the involvement of caudal-related homoeobox transcription factor 2 (CDX2) in tumorigenesis of various cancers. Although CDX2 functions in cancer invasion and metastasis, fewer studies focus on the role of CDX2 during the induction of epithelial-mesenchymal transition (EMT) in colorectal cancer (CRC). Immunohistochemical analysis of CDX2 was performed. A series of in vitro and in vivo experiments were conducted to reveal the role of CDX2 in the invasion and metastasis of CRC. CDX2 was downregulated in CRC tissues and reduced CDX2 correlated with poor prognosis. Knockdown of CDX2 promoted colon cancer cell invasion in vitro and facilitated liver metastasis in vivo with inducing EMT phenotypes. Further investigation indicated that CDX2 retarded Akt and GSK-3β phosphorylation, and thereby diminished Snail expression, β-catenin stabilisation and nuclear translocation. The depletion of β-catenin neutralised the regulation of Slug and ZEB1 by CDX2 knockdown. Mechanistically, CDX2 antagonised PI3K/Akt activity in CRC by modulating PTEN expression. CDX2 directly bound to the promoter of PTEN and transactivated its expression. Our study first uncovered that CDX2 inhibits EMT and metastasis of CRC by regulation of Snail expression and β-catenin stabilisation via transactivation of PTEN expression. Show less
no PDF DOI: 10.1038/s41416-020-01148-1
SNAI1
H-Y Piao, S Guo, Y Wang +1 more · 2021 · Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · Springer · added 2026-04-24
Clinically, hypoxia is associated with increased distant metastasis and poor survival in gastric cancer (GC). In this study, we set out from the cellular interaction to further explain the molecular m Show more
Clinically, hypoxia is associated with increased distant metastasis and poor survival in gastric cancer (GC). In this study, we set out from the cellular interaction to further explain the molecular mechanism of invasion in GC cells under hypoxic conditions. Gastric cancer cells were cultured under 1% O HGC-medium induced NGC dissociated. Long non-coding RNA (lncRNA) prostate cancer gene expression marker 1 (PCGEM1) was specifically expressed in HGC exosomes. HGC-derived PCGEM1-riched exosomes could promote the invasion and migration of NGC. On the mechanism, PCGEM1 maintained stability and reduced the degradation of SNAI1, which could induce the epithelial-mesenchymal transition of GC. LncRNA PCGEM1 was overexpressed in GC cells. And part of the PCGEM1 can be encapsulated into exosomes. These exosomes promoted invasion and migration of other GC cells. We considered PCGEM1 might act as a "scaffold" combined with SNAI1 and prompt the invasion and migration of GC. Show less
no PDF DOI: 10.1007/s12094-020-02412-9
SNAI1
Bin Li, Guihu Zhao, Qiao Zhou +19 more · 2021 · Frontiers in neuroscience · Frontiers · added 2026-04-24
Parkinson's disease (PD) is a complex neurodegenerative disorder with a strong genetic component. A growing number of variants and genes have been reported to be associated with PD; however, there is Show more
Parkinson's disease (PD) is a complex neurodegenerative disorder with a strong genetic component. A growing number of variants and genes have been reported to be associated with PD; however, there is no database that integrate different type of genetic data, and support analyzing of PD-associated genes (PAGs). By systematic review and curation of multiple lines of public studies, we integrate multiple layers of genetic data (rare variants and copy-number variants identified from patients with PD, associated variants identified from genome-wide association studies, differentially expressed genes, and differential DNA methylation genes) and age at onset in PD. We integrated five layers of genetic data (8302 terms) with different levels of evidences from more than 3,000 studies and prioritized 124 PAGs with strong or suggestive evidences. These PAGs were identified to be significantly interacted with each other and formed an interconnected functional network enriched in several functional pathways involved in PD, suggesting these genes may contribute to the pathogenesis of PD. Furthermore, we identified 10 genes were associated with a juvenile-onset (age ≤ 30 years), 11 genes were associated with an early-onset (age of 30-50 years), whereas another 10 genes were associated with a late-onset (age > 50 years). Notably, the AAOs of patients with loss of function variants in five genes were significantly lower than that of patients with deleterious missense variants, while patients with Show less
no PDF DOI: 10.3389/fnins.2021.679568
VPS13C
Jia Cui, Jialin Duan, Jianjie Chu +8 more · 2020 · Aging · Impact Journals · added 2026-04-24
Islet β cell mass reduction induced by glucose fluctuation is crucial for the development and progression of T2DM. Chikusetsu saponin IVa (CHS) had protective effects against DM and related injuries. Show more
Islet β cell mass reduction induced by glucose fluctuation is crucial for the development and progression of T2DM. Chikusetsu saponin IVa (CHS) had protective effects against DM and related injuries. Here we aimed to investigate the role of CHS in β cell injuries and its possible mechanism involved. Isolated rat islets, βTC3 cells and T2DM mice were used in this study. The results showed that CHS restored the secretion activity, promoted β cell survival by increasing β cell proliferation and decreasing apoptosis which induced by intermittent high glucose (IHG). Show less
📄 PDF DOI: 10.18632/aging.102702
GIPR
Ruijuan Guo, Yuqing Sun, Huili Li +2 more · 2020 · Neurochemistry international · Elsevier · added 2026-04-24
It is unclear whether glucose-dependent insulinotropic polypeptide receptor (GIPR) signaling plays an important role in spinal nociception. We hypothesized that the spinal GIPR is implicated in centra Show more
It is unclear whether glucose-dependent insulinotropic polypeptide receptor (GIPR) signaling plays an important role in spinal nociception. We hypothesized that the spinal GIPR is implicated in central sensitization of postoperative pain. Our data showed that the cumulative pain scores peaked at 3 h, kept at a high level at 1 d after incision, gradually decreased afterwards and returned to the baseline values at 5 d after incision. Correspondingly, the expression of GIPR in spinal cord dorsal horn peaked at 1 d after incision, and returned to the baseline value at 5 d after incision. The double-labeling immunofluorescence demonstrated that spinal GIPR was expressed in dorsal horn neurons, but not in astrocyte or microglial cells. At 1 d after incision, the effects of intrathecal saline, GIPR antagonist (Pro3)GIP on pain behaviors were investigated. Our data showed that at 30 min and 60 min following intrathecal treatments of 300 ng (Pro3)GIP, the cumulative pain scores were decreased and paw withdrawal thresholds to mechanical stimuli were increased when compared to those immediately before intrathecal treatments. Accordingly, at 30 min after intrathecal injections, the membrane translocation levels of PKCγ and the GluR1 expression in postsynaptic membrane in ipsilateral dorsal horns to the incision were significantly upregulated in rats with intrathecal saline injections, as compared to normal control group. At 30 min after intrathecal treatment, (Pro3)GIP inhibited the membrane translocation levels of PKCγ and the GluR1 expression in postsynaptic membrane in ipsilateral dorsal horns. Our study indicates that upregulation of spinal GIPR may contribute to pain hypersensitivity through inducing membrane translocation level of PKCγ and synaptic target of AMPA receptor GluR1 subunits in ipsilateral dorsal horns of rats with plantar incision. Show less
no PDF DOI: 10.1016/j.neuint.2019.104651
GIPR
Keping Yu, Li Li, Lan Zhang +2 more · 2020 · Gene · Elsevier · added 2026-04-24
Obesity is a huge burden of the world. It is commonly recognized that dietary structure and physical inactivity is essential in the progress of obesity. However, some individuals still face the troubl Show more
Obesity is a huge burden of the world. It is commonly recognized that dietary structure and physical inactivity is essential in the progress of obesity. However, some individuals still face the trouble of obese even though they live a healthy life. Except for the combination of diseases, the operation of both lifestyle and genetic features contributes to obesity. Melanocortin-4-receptor (MC4R) gene is one of the known hereditary factors of obesity. rs17782313, a single nucleotide variant in MC4R gene, has been reported unclear results in whether it plays a role in obesity. This meta-analysis is to estimate the association between MC4R rs17782313 genotype and obesity. A systematic literature retrieval was conducted in four databases: PubMed, Embase, Web of Science and Cochrane Library with specific search strategy. Select qualified studies to identify relevant studies. Odds ratios (ORs) with 95% confidence intervals (CI), P value and I 6 eligible studies involving 3133 obese cases and 3123 normal-weight participants were selected from 378 articles. Allele B of MC4R rs17782313 present a statistically significant association with obesity under allele contrast model (OR = 1.325, 95%CI: 1.219-1.439), dominant model (OR = 1.320, 95%CI: 1.184-1.472), recessive model (OR = 1.690, 95%CI: 1.420-2.011) and homozygous type of co-dominant model (OR = 1.925, 95%CI: 1.590-2.330), respectively, and P < 0.05. Mutated MC4R rs17782313 is associated with higher risk of obesity. People with homozygous mutant genotype of MC4R rs17782313 would be more likely to suffer from obesity, while heterozygous mutant genotype needs further studies to clarify. Show less
no PDF DOI: 10.1016/j.gene.2020.144372
MC4R
Yezi Kong, Chenxu Zhao, Yan Huang +7 more · 2020 · IUBMB life · Wiley · added 2026-04-24
In dairy cows, fatty liver is one of the most common metabolic diseases that occurs during the periparturient period. Angiopoietin-like protein 4 (ANGPTL4) is a well-known downstream target of peroxis Show more
In dairy cows, fatty liver is one of the most common metabolic diseases that occurs during the periparturient period. Angiopoietin-like protein 4 (ANGPTL4) is a well-known downstream target of peroxisome proliferator-activated receptors (PPARs), which regulate the glucose and fatty acid metabolisms. The inhibition of lipoprotein lipase (LPL) activity interferes with the storage of triglycerides (TG) in adipocytes, which plays an essential role in lipid metabolism in rodents. However, it remains unclear whether ANGPTL4 is involved in the pathological process of fatty liver in dairy cows as a result of the regulation of the hepatocellular lipid transport system. This study intended to investigate the effect of ANGPTL4 on the very-low-density lipoprotein (VLDL) assembly and secretion in bovine hepatocytes. Bovine hepatocytes were isolated using a modified two-step perfusion and collagenase digestion process, and treated with different concentrations of ANGPTL4 (0, 4, 12, and 24 ng/ml) for 24 hr. The results showed that a high concentration of ANGPTL4 could significantly increase the extracellular concentration of VLDL while reducing the intracellular content of TG. Thus, it was confirmed that ANGPTL4 could promote the transport of TG in the form of VLDL by partially regulating the expression of related proteins in hepatocytes, thereby contributing to the partial adaptive regulation of lipid transport in dairy cows. Show less
no PDF DOI: 10.1002/iub.2403
ANGPTL4
Julie Hahn, Yi-Ping Fu, Michael R Brown +42 more · 2020 · PloS one · PLOS · added 2026-04-24
Genome-wide association studies have identified multiple genomic loci associated with coronary artery disease, but most are common variants in non-coding regions that provide limited information on ca Show more
Genome-wide association studies have identified multiple genomic loci associated with coronary artery disease, but most are common variants in non-coding regions that provide limited information on causal genes and etiology of the disease. To overcome the limited scope that common variants provide, we focused our investigation on low-frequency and rare sequence variations primarily residing in coding regions of the genome. Using samples of individuals of European ancestry from ten cohorts within the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium, both cross-sectional and prospective analyses were conducted to examine associations between genetic variants and myocardial infarction (MI), coronary heart disease (CHD), and all-cause mortality following these events. For prevalent events, a total of 27,349 participants of European ancestry, including 1831 prevalent MI cases and 2518 prevalent CHD cases were used. For incident cases, a total of 55,736 participants of European ancestry were included (3,031 incident MI cases and 5,425 incident CHD cases). There were 1,860 all-cause deaths among the 3,751 MI and CHD cases from six cohorts that contributed to the analysis of all-cause mortality. Single variant and gene-based analyses were performed separately in each cohort and then meta-analyzed for each outcome. A low-frequency intronic variant (rs988583) in PLCL1 was significantly associated with prevalent MI (OR = 1.80, 95% confidence interval: 1.43, 2.27; P = 7.12 × 10-7). We conducted gene-based burden tests for genes with a cumulative minor allele count (cMAC) ≥ 5 and variants with minor allele frequency (MAF) < 5%. TMPRSS5 and LDLRAD1 were significantly associated with prevalent MI and CHD, respectively, and RC3H2 and ANGPTL4 were significantly associated with incident MI and CHD, respectively. No loci were significantly associated with all-cause mortality following a MI or CHD event. This study identified one known locus (ANGPTL4) and four new loci (PLCL1, RC3H2, TMPRSS5, and LDLRAD1) associated with cardiovascular disease risk that warrant further investigation. Show less
📄 PDF DOI: 10.1371/journal.pone.0230035
ANGPTL4
Yang An, Qiang Wang, Fengjie Sun +9 more · 2020 · Genes · MDPI · added 2026-04-24
Uterine carcinosarcoma (UCS) is a type of rare and aggressive tumor. The standard treatment for UCS involves surgical treatment followed by radiochemotherapy. Clinical outcomes of UCS patients are poo Show more
Uterine carcinosarcoma (UCS) is a type of rare and aggressive tumor. The standard treatment for UCS involves surgical treatment followed by radiochemotherapy. Clinical outcomes of UCS patients are poor due to high metastasis and relapse rate. Therefore, new targeted therapy strategies for UCS are needed. Because UCS is highly heterogenous, it is critical to identify and develop prognostic biomarkers to distinguish molecular subtypes of UCS for better treatment guidance. Using gene expression profiles and clinical follow-up data, we developed an online consensus survival analysis tool named OSucs. This web tool allows researchers to conveniently analyze the prognostic abilities of candidate genes in UCS. To test the reliability of this server, we analyzed five previously reported prognostic biomarkers, all of which showed significant prognostic impacts. In addition, ETV4 (ETS variant transcription factor 4), ANGPTL4 (Angiopoietin-like protein 4), HIST1H1C (Histone cluster 1 H1 family member c) and CTSV (Cathepsin V) showed prognostic potential in a molecular subtype-specific manner. We built a platform for researchers to analyze if genes have prognostic potentials in UCS. Show less
📄 PDF DOI: 10.3390/genes11091040
ANGPTL4
Zhe Wang, Han Chen, Traci M Bartz +38 more · 2020 · Circulation. Genomic and precision medicine · added 2026-04-24
Alcohol intake influences plasma lipid levels, and such effects may be moderated by genetic variants. We aimed to characterize the role of aggregated rare and low-frequency protein-coding variants in Show more
Alcohol intake influences plasma lipid levels, and such effects may be moderated by genetic variants. We aimed to characterize the role of aggregated rare and low-frequency protein-coding variants in gene by alcohol consumption interactions associated with fasting plasma lipid levels. In the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium, fasting plasma triglycerides and high- and low-density lipoprotein cholesterol were measured in 34 153 individuals with European ancestry from 5 discovery studies and 32 277 individuals from 6 replication studies. Rare and low-frequency functional protein-coding variants (minor allele frequency, ≤5%) measured by an exome array were aggregated by genes and evaluated by a gene-environment interaction test and a joint test of genetic main and gene-environment interaction effects. Two dichotomous self-reported alcohol consumption variables, current drinker, defined as any recurrent drinking behavior, and regular drinker, defined as the subset of current drinkers who consume at least 2 drinks per week, were considered. We discovered and replicated 21 gene-lipid associations at 13 known lipid loci through the joint test. Eight loci ( In conclusion, this study applied new gene-based statistical approaches and suggested that rare and low-frequency genetic variants interacted with alcohol consumption on lipid levels. Show less
📄 PDF DOI: 10.1161/CIRCGEN.119.002772
ANGPTL4
Yan Q Chen, Thomas G Pottanat, Robert W Siegel +10 more · 2020 · Journal of lipid research · added 2026-04-24
Angiopoietin-like protein (ANGPTL)8 has been implicated in metabolic syndrome and reported to regulate adipose FA uptake through unknown mechanisms. Here, we studied how complex formation of ANGPTL8 w Show more
Angiopoietin-like protein (ANGPTL)8 has been implicated in metabolic syndrome and reported to regulate adipose FA uptake through unknown mechanisms. Here, we studied how complex formation of ANGPTL8 with ANGPTL3 or ANGPTL4 varies with feeding to regulate LPL. In human serum, ANGPTL3/8 and ANGPTL4/8 complexes both increased postprandially, correlated negatively with HDL, and correlated positively with all other metabolic syndrome markers. ANGPTL3/8 also correlated positively with LDL-C and blocked LPL-facilitated hepatocyte VLDL-C uptake. LPL-inhibitory activity of ANGPTL3/8 was >100-fold more potent than that of ANGPTL3, and LPL-inhibitory activity of ANGPTL4/8 was >100-fold less potent than that of ANGPTL4. Quantitative analyses of inhibitory activities and competition experiments among the complexes suggested a model in which localized ANGPTL4/8 blocks the LPL-inhibitory activity of both circulating ANGPTL3/8 and localized ANGPTL4, allowing lipid sequestration into fat rather than muscle during the fed state. Supporting this model, insulin increased ANGPTL3/8 secretion from hepatocytes and ANGPTL4/8 secretion from adipocytes. These results suggest that low ANGPTL8 levels during fasting enable ANGPTL4-mediated LPL inhibition in fat tissue to minimize adipose FA uptake. During feeding, increased ANGPTL8 increases ANGPTL3 inhibition of LPL in muscle via circulating ANGPTL3/8, while decreasing ANGPTL4 inhibition of LPL in adipose tissue through localized ANGPTL4/8, thereby increasing FA uptake into adipose tissue. Excessive caloric intake may shift this system toward the latter conditions, possibly predisposing to metabolic syndrome. Show less
📄 PDF DOI: 10.1194/jlr.RA120000781
ANGPTL4
William Yang, Elie Khoury, Qianyu Guo +10 more · 2020 · Oncogene · Nature · added 2026-04-24
The BRAF
📄 PDF DOI: 10.1038/s41388-020-1240-5
ANGPTL4
Kaifeng Guo, Pan Pan, Mian Wu +3 more · 2020 · Molecular and cellular endocrinology · Elsevier · added 2026-04-24
Angiopoietin-like-4 (ANGPTL4) is reported to mediate proteinuria in some types of glomerulonephropathy. However, the mechanism underlying the effect on podocytes of ANGPTL4 under pathologic conditions Show more
Angiopoietin-like-4 (ANGPTL4) is reported to mediate proteinuria in some types of glomerulonephropathy. However, the mechanism underlying the effect on podocytes of ANGPTL4 under pathologic conditions in diabetic nephropathy (DN) is unclear. We investigated the role of ANGPTL4 in the pathogenesis of DN. In DN rats, elevated ANGPTL4 expression was associated with increased proteinuria, glomerular hypertrophy, and ultrastructural changes in podocytes. In vitro, hyperglycemia induced the upregulation of ANGPTL4, which led to activation of integrin-β1/FAK signaling with increased apoptosis of podocytes and actin cytoskeleton derangement. These pathological changes were reversed by transfection with a lentivirus expressing short hairpin RNA against integrin-β1 or an ANGPTL4-neutralizing antibody in vitro. Furthermore, supplementation with the sialic acid precursor ManNAc reversed these pathological changes and conferred renoprotection in a mouse model of DN. Our findings suggest that ANGPTL4 mediates high glucose-induced loss of podocytes by modulating their detachment and apoptosis in vivo and in vitro. This study deepens our understanding of the mechanisms of podocyte loss in DN and shows targeting ANGPTL4-related signaling has therapeutic potential for DN. Show less
no PDF DOI: 10.1016/j.mce.2020.110730
ANGPTL4
Jing Li, Liang Li, DongMing Guo +6 more · 2020 · Clinica chimica acta; international journal of clinical chemistry · Elsevier · added 2026-04-24
Hypertriglyceridemia is a risk factor for a series of diseases, such as cardiovascular disease (CVD), diabetes and nonalcoholic fatty liver disease (NAFLD). Angiopoietin-like proteins (ANGPTLs) family Show more
Hypertriglyceridemia is a risk factor for a series of diseases, such as cardiovascular disease (CVD), diabetes and nonalcoholic fatty liver disease (NAFLD). Angiopoietin-like proteins (ANGPTLs) family, especially ANGPTL3, ANGPTL4 and ANGPTL8, which regulate lipoprotein lipase (LPL) activity, play pivotal roles in triglyceride (TG) metabolism and related diseases/complications. There are many transcriptional and post-transcriptional factors that participate in physiological and pathological regulation of ANGPTLs to affect triglyceride metabolism. This review is intended to focus on the similarity and difference in the expression, structural features, regulation profile of the three ANGPTLs and inhibitory models for LPL. Description of the regulatory factors of ANGPTLs and the properties in regulating the lipid metabolism involved in the underlying mechanisms in pathological effects on diseases will provide potential therapeutic approaches for the treatment of dyslipidemia related diseases. Show less
no PDF DOI: 10.1016/j.cca.2019.12.029
ANGPTL4
Yanjun Guo, Pamela M Rist, Iyas Daghlas +5 more · 2020 · Nature communications · Nature · added 2026-04-24
Blood pressure (BP) was inconsistently associated with migraine and the mechanisms of BP-lowering medications in migraine prophylaxis are unknown. Leveraging large-scale summary statistics for migrain Show more
Blood pressure (BP) was inconsistently associated with migraine and the mechanisms of BP-lowering medications in migraine prophylaxis are unknown. Leveraging large-scale summary statistics for migraine (N Show less
📄 PDF DOI: 10.1038/s41467-020-17002-0
ANKDD1B
Zhuoran Han, Jingfeng Sun, Anli Wang +4 more · 2020 · Fish & shellfish immunology · Elsevier · added 2026-04-24
Fish intestine is an important constituent of the mucosal immune system. The gut and gut-associated lymphoid tissue construct a local immune environment. A Shewanella algae strain was previously repor Show more
Fish intestine is an important constituent of the mucosal immune system. The gut and gut-associated lymphoid tissue construct a local immune environment. A Shewanella algae strain was previously reported to be a pathogen causing ascitic disease accompanied with intestinal inflammation in Cynoglossus semilaevis. This study aimed to investigate the intestine immune response in C. semilaevis to S. algae infection at the protein level. Two-dimensional electrophoresis coupled with mass spectrometry proteomics was utilized to compare protein expression in the intestines from normal and S. algae-infected C. semilaevis. A total of 70 differentially expressed proteins (DEPs), consisting of 16 upregulated and 54 downregulated proteins, were identified in the intestine tissue of C. Semilaevis. These protein expression changes were further validated using western blot analysis and quantitative real-time PCR. Gene ontology enrichment analysis showed that these 70 DEPs could be assigned across three categories: "cellular components", "molecular function", and "biological process". Forty-one DEPs (six up-regulated and 35 down-regulated proteins) related to metabolic processes were identified. In addition, 20 DEPs (eight up-regulated and 12 down-regulated proteins) related to stress and immune responses were identified. A protein-protein interaction network generated by the STRING (Search Tool for the Retrieval of Interacting Genes/protein) revealed that 30 DEPs interacted with one another to form an integrated network. Among them, 29 DEPs were related to stress, immune, and metabolism processes. In the network, some of the immune related proteins (C9, FGB, KNG1, apolipoprotein A-IV-like, and PDIA3) were up-regulated and most DEPs involved in metabolism processes were down-regulated. These results indicate that the immune defense response of the intestine was activated and the intestinal function associated with metabolism processes was disturbed. This study provides valuable information for further research into the functions of these DEPs in fish. Show less
no PDF DOI: 10.1016/j.fsi.2020.06.013
APOA4
Jing Gong, Hong-Xia Wang, Yeh-Hsing Lao +8 more · 2020 · Advanced materials (Deerfield Beach, Fla.) · Wiley · added 2026-04-24
Recent advances in CRISPR present attractive genome-editing toolsets for therapeutic strategies at the genetic level. Here, a liposome-coated mesoporous silica nanoparticle (lipoMSN) is reported as an Show more
Recent advances in CRISPR present attractive genome-editing toolsets for therapeutic strategies at the genetic level. Here, a liposome-coated mesoporous silica nanoparticle (lipoMSN) is reported as an effective CRISPR delivery system for multiplex gene-editing in the liver. The MSN provides efficient loading of Cas9 plasmid as well as Cas9 protein/guide RNA ribonucleoprotein complex (RNP), while liposome-coating offers improved serum stability and enhanced cell uptake. Hypothesizing that loss-of-function mutation in the lipid-metabolism-related genes pcsk9, apoc3, and angptl3 would improve cardiovascular health by lowering blood cholesterol and triglycerides, the lipoMSN is used to deliver a combination of RNPs targeting these genes. When targeting a single gene, the lipoMSN achieved a 54% gene-editing efficiency, besting the state-of-art Lipofectamine CRISPRMax. For multiplexing, lipoMSN maintained significant gene-editing at each gene target despite reduced dosage of target-specific RNP. By delivering combinations of targeting RNPs in the same nanoparticle, synergistic effects on lipid metabolism are observed in vitro and vivo. These effects, such as a 50% decrease in serum cholesterol after 4 weeks of post-treatment with lipoMSN carrying both pcsk9 and angptl3-targeted RNPs, could not be reached with a single gene-editing approach. Taken together, this lipoMSN represents a versatile platform for the development of efficient, combinatorial gene-editing therapeutics. Show less
📄 PDF DOI: 10.1002/adma.202003537
APOC3
Mengmeng Guo, Yitong Xu, Zhao Dong +7 more · 2020 · Circulation research · added 2026-04-24
no PDF DOI: 10.1161/CIRCRESAHA.120.317686
APOC3